Patent details
LUC00253 Product Name: Riprétinib ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- LUC00253
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP172084089
- Legal Status:
- Inactive
- Application number:
- LUC00253
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/21/1569
- Marketing Authorization Type:
- Marketing Authorization Date:
- 24/11/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 05/04/2022
- First Marketing Authorization date:
- 24/11/2021
- Grant date:
- 04/03/2025
- Activation date:
- Publication date:
- 06/04/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 24/11/2036
- SPC Extension Expiration:
- 24/11/2036
- Rejection date:
- Withdrawal date:
Owner
- From:
- 05/04/2022
- Name:
- Deciphera Pharmaceuticals, LLC
- Address:
- 643 Massachusetts, Suite 200, Lawrence, Kansas 66044, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 05/04/2022
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/06
- Publication date:
- 03/05/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/05
- Publication date:
- 07/04/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 30/06/2032
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 05/04/2022 | Summary of the product caracteristics | 33 |
| 06/04/2022 | Outgoing Correspondence | 1 |
| 05/04/2022 | General Document | 2 |
| 05/04/2022 | Incoming Correspondence (Post) | 1 |
| 05/04/2022 | Application Form | 4 |
| 05/04/2022 | Marketing authorization | 3 |
| 05/04/2022 | General Document | 34 |
| 05/04/2022 | MA publication | 12 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |
| 06/04/2022 | Publication | 1 |
| 04/03/2025 | Publication | 1 |
| 04/03/2025 | Certificate | 1 |
| 04/03/2025 | Outgoing Correspondence | 1 |